Home Categories API Pentagastrin
A6631612

Pentagastrin , ≥95%(HPLC) , 5534-95-2

Synonym(s):
N-t-Boc-β-Ala-Trp-Met-Asp-Phe amide

CAS NO.:5534-95-2

Empirical Formula: C37H49N7O9S

Molecular Weight: 767.9

MDL number: MFCD00076515

EINECS: 226-889-7

Pack Size Price Stock Quantity
25MG RMB896.00 In Stock
100MG RMB2446.40 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 229-230° (dec)
alpha  D22 -28.8 ±0.5° (DMF)
Boiling point: 1196.6±65.0 °C(Predicted)
Density  1.303±0.06 g/cm3(Predicted)
storage temp.  -20°C
solubility  Practically insoluble in water; soluble in 5M ammonia and in dimethylformamide; slightly soluble in ethanol (96%).
form  powder
pka 4.19±0.10(Predicted)
color  White to off-white
Sequence N-t-Boc-β-Ala-Trp-Met-Asp-Phe-NH2
InChIKey NEYNJQRKHLUJRU-DZUOILHNSA-N

Description and Uses

Pentagastrin is a synthetic polypeptide and cholecystokinin-2 (CCK2) receptor agonist. It binds selectively to CCK2 receptors in guinea pig brain over CCK1 receptors in rat pancreas (IC50s = 11 and 1,100 nM, respectively). Pentagastrin increases calcium influx and polyphosphoinositide turnover in rat GH3 pituitary cells (EC50s = 23 and 3.9 nM, respectively). It also increases histidine decarboxylase activity in mucous- and endocrine cell-enriched isolated rabbit fundic mucosal cells (EC50 = 2.9 nM). Pentagastrin induces contraction of isolated pig ileum smooth muscle cells in vitro (EC50 = 30 pM). It increases gastric acid and pepsin secretion in conscious cats in vivo (ED50s = 1.29 and 57.3 nmol/kg2 per hour, respectively). Formulations containing pentagastrin have previously been used as a diagnostic aid to evaluate gastric acid secretory function.

anesthetic (local)

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302+H312+H332
Hazard Codes  T
Risk Statements  61-36/38-20/21
Safety Statements  53-45-36/37/39-22
WGK Germany  1
RTECS  AY2970000

RELATED PRODUCTS